Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review

Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review


  • Products Id :- GDPH28215SA
  • |
  • Pages: 31
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Chiesi Farmaceutici SpA-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

Chiesi Farmaceutici SpA (Chiesi) researches, develops, produces and commercializes novel medicines with focus on respiratory, neonatology, rare disease and special care therapeutic areas. The company provides products for the treatment of chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis, ankylosing spondylitis, hypertension, percutaneous coronary intervention, apnoea of prematurity, respiratory distress syndrome (RDS), lipoprotein lipase deficiency (LPLD), limbal stem cell deficiency (LSCD), inflammatory bowel diseases and renal and liver failure-solid organ transplant (SOT). The company operates production sites in Parma, Italy; Blois, France; and Santana De Parnaiba, Brazil; and carries out research and development (R&D) activities at its new R&D center in Parma and at laboratories in Paris, Chippenham (UK), Cary (US), Lidingo (Sweden) and Hillerod (Denmark). Chiesi is headquartered in Parma, Italy.

Chiesi Farmaceutici SpA Key Recent Developments

Jul 31,2018: Inhalation Sciences in 3-year research project with 5 organizations, including purchase of new PreciseInhale system by Chiesi

Mar 27,2018: Construction Launch For New Chiesi Farmaceutici Headquarters

Feb 05,2018: Amiko receives CE mark for three novel inhaler sensors

Aug 30,2017: Inhalation Sciences Sweden- PreciseInhale achieves positive results in Chiesi tests

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Chiesi Farmaceutici SpA-Key Facts 5

Chiesi Farmaceutici SpA-Key Employees 6

Chiesi Farmaceutici SpA-Major Products and Services 7

Chiesi Farmaceutici SpA-History 9

Chiesi Farmaceutici SpA-Company Statement 12

Chiesi Farmaceutici SpA-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 16

Company Overview 16

Chiesi Farmaceutici SpA-Business Description 17

Chiesi Farmaceutici SpA-Corporate Strategy 18

Chiesi Farmaceutici SpA-SWOT Analysis 19

SWOT Analysis-Overview 19

Chiesi Farmaceutici SpA-Strengths 19

Chiesi Farmaceutici SpA-Weaknesses 20

Chiesi Farmaceutici SpA-Opportunities 21

Chiesi Farmaceutici SpA-Threats 22

Chiesi Farmaceutici SpA-Key Competitors 23

Section 3-Company's Lifesciences Financial Deals and Alliances 24

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 25

Chiesi Farmaceutici SpA, Recent Deals Summary 26

Section 4-Company's Recent Developments 27

Jul 31, 2018: Inhalation Sciences in 3-year research project with 5 organizations, including purchase of new PreciseInhale system by Chiesi 27

Mar 27, 2018: Construction Launch For New Chiesi Farmaceutici Headquarters 28

Feb 05, 2018: Amiko receives CE mark for three novel inhaler sensors 29

Aug 30, 2017: Inhalation Sciences Sweden- PreciseInhale achieves positive results in Chiesi tests 30

Section 5-Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31

List of Figures

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 25

List of Tables

Chiesi Farmaceutici SpA, Key Facts 5

Chiesi Farmaceutici SpA, Key Employees 6

Chiesi Farmaceutici SpA, Major Products and Services 7

Chiesi Farmaceutici SpA, History 9

Chiesi Farmaceutici SpA, Subsidiaries 13

Chiesi Farmaceutici SpA, Key Competitors 23

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 25

Chiesi Farmaceutici SpA, Recent Deals Summary 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Zambon Italia Srl

SIFI SpA

Siena Biotech SpA

Newron Pharmaceuticals SpA

FB Health SpA

Cosmo Pharmaceuticals NV

Chiesi Farmaceutici SpA, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.

select a license
Single User License
USD 125 INR 8916
Site License
USD 250 INR 17833
Corporate User License
USD 375 INR 26749

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com